176 related articles for article (PubMed ID: 25461892)
1. Piperazine derivatives: synthesis, inhibition of the Mycobacterium tuberculosis enoyl-acyl carrier protein reductase and SAR studies.
Rotta M; Pissinate K; Villela AD; Back DF; Timmers LF; Bachega JF; de Souza ON; Santos DS; Basso LA; Machado P
Eur J Med Chem; 2015 Jan; 90():436-47. PubMed ID: 25461892
[TBL] [Abstract][Full Text] [Related]
2. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis.
Bonnac L; Gao GY; Chen L; Felczak K; Bennett EM; Xu H; Kim T; Liu N; Oh H; Tonge PJ; Pankiewicz KW
Bioorg Med Chem Lett; 2007 Aug; 17(16):4588-91. PubMed ID: 17560106
[TBL] [Abstract][Full Text] [Related]
4. Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis.
Sharma SK; Kumar G; Kapoor M; Surolia A
Biochem Biophys Res Commun; 2008 Mar; 368(1):12-7. PubMed ID: 17996734
[TBL] [Abstract][Full Text] [Related]
5. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade.
Holas O; Ondrejcek P; Dolezal M
J Enzyme Inhib Med Chem; 2015; 30(4):629-48. PubMed ID: 25383419
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
Subba Rao G; Vijayakrishnan R; Kumar M
Chem Biol Drug Des; 2008 Nov; 72(5):444-9. PubMed ID: 19012578
[TBL] [Abstract][Full Text] [Related]
8. Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach.
Stigliani JL; Arnaud P; Delaine T; Bernardes-Génisson V; Meunier B; Bernadou J
J Mol Graph Model; 2008 Nov; 27(4):536-45. PubMed ID: 18955002
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel potential antibiotics for tuberculosis by in silico structure-based drug screening.
Izumizono Y; Arevalo S; Koseki Y; Kuroki M; Aoki S
Eur J Med Chem; 2011 May; 46(5):1849-56. PubMed ID: 21397998
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.
He X; Alian A; Ortiz de Montellano PR
Bioorg Med Chem; 2007 Nov; 15(21):6649-58. PubMed ID: 17723305
[TBL] [Abstract][Full Text] [Related]
11. Aqueous Molecular Dynamics Simulations of the M. tuberculosis Enoyl-ACP Reductase-NADH System and Its Complex with a Substrate Mimic or Diphenyl Ethers Inhibitors.
da Silva Lima CH; de Alencastro RB; Kaiser CR; de Souza MV; Rodrigues CR; Albuquerque MG
Int J Mol Sci; 2015 Oct; 16(10):23695-722. PubMed ID: 26457706
[TBL] [Abstract][Full Text] [Related]
12. Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding.
Duca G; Pogrebnoi S; Boldescu V; Aksakal F; Uncu A; Valica V; Uncu L; Negres S; Nicolescu F; Macaev F
Curr Top Med Chem; 2019; 19(8):609-619. PubMed ID: 30834838
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis.
He X; Alian A; Stroud R; Ortiz de Montellano PR
J Med Chem; 2006 Oct; 49(21):6308-23. PubMed ID: 17034137
[TBL] [Abstract][Full Text] [Related]
14. Discovery of InhA inhibitors with anti-mycobacterial activity through a matched molecular pair approach.
Kanetaka H; Koseki Y; Taira J; Umei T; Komatsu H; Sakamoto H; Gulten G; Sacchettini JC; Kitamura M; Aoki S
Eur J Med Chem; 2015 Apr; 94():378-85. PubMed ID: 25778993
[TBL] [Abstract][Full Text] [Related]
15. An inorganic iron complex that inhibits wild-type and an isoniazid-resistant mutant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
Oliveira JS; Sousa EH; Basso LA; Palaci M; Dietze R; Santos DS; Moreira IS
Chem Commun (Camb); 2004 Feb; (3):312-3. PubMed ID: 14740053
[TBL] [Abstract][Full Text] [Related]
16. Structural modification of a novel inhibitor for mycobacterium enoyl-acyl carrier protein reductase assisted by
Taira J; Nagano T; Kitamura M; Yamaguchi M; Sakamoto H; Aoki S
Int J Mycobacteriol; 2020; 9(1):12-17. PubMed ID: 32474482
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents.
Kamal A; Reddy BV; Sridevi B; Ravikumar A; Venkateswarlu A; Sravanthi G; Sridevi JP; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2015 Sep; 25(18):3867-72. PubMed ID: 26253635
[TBL] [Abstract][Full Text] [Related]
18. Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis.
Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
Eur J Med Chem; 2014 Oct; 86():613-27. PubMed ID: 25218910
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate.
Rozwarski DA; Vilchèze C; Sugantino M; Bittman R; Sacchettini JC
J Biol Chem; 1999 May; 274(22):15582-9. PubMed ID: 10336454
[TBL] [Abstract][Full Text] [Related]
20. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations.
Stigliani JL; Bernardes-Génisson V; Bernadou J; Pratviel G
Org Biomol Chem; 2012 Aug; 10(31):6341-9. PubMed ID: 22751934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
